Vimarsana
Biggest News Aggregation in the World

Page 2 - Syncona Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Syncona Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Syncona Ltd Today - Breaking & Trending Today

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates EGLE, - Vimarsana News

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates EGLE,

NEW YORK, Jan. 27, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential...

Syncona notes FDA acceptance of Autolus's BLA for obe-cel - Vimarsana News

Syncona notes FDA acceptance of Autolus's BLA for obe-cel

Syncona Ltd - London-based investor in healthcare companies - The US Food & Drug Administration accepts Autolus Therapeutics PLC's biologics licence application for obe-cel for patients with...

Gene therapy market size to grow by USD 4,613.9 million from 2022 to 2027 | North America is estimated to contribute 39% to the growth - Vimarsana News

Gene therapy market size to grow by USD 4,613.9 million from 2022 to 2027 | North America is estimated to contribute 39% to the growth

/PRNewswire/ -- Technavio categorizes the global gene therapy market size as estimated to increase by USD 4,613.9 million between 2022 and 2027. The market's...

Syncona portfolio company Beacon presents data from AGTC-501 trial - Vimarsana News

Syncona portfolio company Beacon presents data from AGTC-501 trial

Syncona portfolio company Beacon presents data from AGTC-501 trial

Syncona notes Beacon's "encouraging" AGTC-501 trial data - Vimarsana News

Syncona notes Beacon's "encouraging" AGTC-501 trial data

Syncona Ltd - London-based investor in healthcare companies - Says portfolio company, Beacon Therapeutics has presented three-month data from the phase 2 Skyline trial of its viral vector-based gene...